Deborah Roby
Last active: 4/1/2020


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-β burden in a mouse model of Alzheimer's disease. Roby DA, Ruiz F, Kermath BA, Voorhees JR, Niehoff M, Zhang J, Morley JE, Musiek ES, Farr SA, Burris TP (2019) PLoS One 14(4): e0215004
    › Primary publication · 30973894 (PubMed) · PMC6459530 (PubMed Central)
  2. Metformin Improves Learning and Memory in the SAMP8 Mouse Model of Alzheimer's Disease. Farr SA, Roesler E, Niehoff ML, Roby DA, McKee A, Morley JE (2019) J Alzheimers Dis 68(4): 1699-1710
    › Primary publication · 30958364 (PubMed)
  3. Inhibition of Glycogen Synthase Kinase 3β as a Treatment for the Prevention of Cognitive Deficits after a Traumatic Brain Injury. Farr SA, Niehoff ML, Kumar VB, Roby DA, Morley JE (2019) J Neurotrauma 36(11): 1869-1875
    › Primary publication · 30704365 (PubMed)


Featured Affiliation

No featured affiliations

    View all affiliations

    Contact Information

    No address provided
    +1 (615) 343-0580 (p)

    Keywords & MeSH Terms

    MeSH terms are retrieved from PubMed records. Learn more.

    Key: MeSH Term Keyword

    Alzheimer Disease Amyloid beta-Peptides Animals Brain Injuries, Traumatic Cognitive Dysfunction Disease Models, Animal Disks Large Homolog 4 Protein Glycogen Synthase Kinase 3 beta Hippocampus Male Maze Learning Memory Metformin Mice Neuroprotective Agents Oligonucleotides, Antisense Peptide Fragments Pyrrolidines Thiophenes Treatment Outcome